Emtricitabine Unknown Status Phase 4 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02285374Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity
NCT00885664Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
NCT00759070Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism